Physician profile
Zhao Lu
NPI 1043389174
$18,206.79
in general payments reported to CMS, 2019-2025
65 companies · $3,178 in 2025
The $3,178 reported for 2025 was more than what 75% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,029 · 2020: $1,386 · 2021: $2,920 · 2022: $2,694 · 2023: $3,077 · 2024: $2,922 · 2025: $3,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,694 · Education: $1,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,694.41 |
| Education | $1,482.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,976.70 | 2019-2025 | Darzalex, Erleada, Tecvayli |
| Pfizer INC. | $1,616.72 | 2019-2025 | |
| Seagen INC. | $1,127.89 | 2019-2024 | Adcetris, Padcev, Tukysa |
| Novartis Pharmaceuticals Corporation | $1,028.80 | 2019-2025 | |
| Incyte Corporation | $872.47 | 2020-2025 | Jakafi, Monjuvi, Pemazyre |
| Astrazeneca Pharmaceuticals Lp | $806.14 | 2019-2025 | Airsupra, Calquence, Enhertu |
| Merck Sharp & Dohme LLC | $789.76 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Astellas Pharma US INC | $666.23 | 2019-2025 | Xtandi, Padcev, Xospata |
| Array Biopharma INC | $646.09 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Celgene Corporation | $560.12 | 2019-2025 | Reblozyl |
| Jazz Pharmaceuticals INC. | $473.77 | 2020-2025 | |
| Genzyme Corporation | $470.94 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $446.63 | 2019-2025 | Eliquis, Opdivo, Krazati |
| Rigel Pharmaceuticals, INC. | $421.42 | 2019-2025 | Rezlidhia, Gavreto, Tavalisse |
| Amgen INC. | $402.82 | 2019-2023 | Kyprolis |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $401.32 | 2019-2024 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $348.74 | 2020-2025 | Libtayo, Lynozyfic |
| Ipsen Biopharmaceuticals, INC | $314.03 | 2019-2023 | Onivyde, Somatuline Depot |
| Eisai INC. | $307.71 | 2019-2025 | |
| Abbvie INC. | $305.68 | 2022-2025 | |
| Lilly USA, LLC | $302.56 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $283.15 | 2019-2022 | |
| Sobi, INC | $277.17 | 2022-2025 | |
| Genentech USA, INC. | $209.76 | 2019-2022 | |
| Gilead Sciences, INC. | $208.01 | 2019-2025 | Trodelvy |
| Daiichi Sankyo INC. | $205.52 | 2019-2025 | Injectafer, Enhertu, Datroway |
| Pharmacosmos Therapeutics INC. | $164.47 | 2022-2024 | Monoferric |
| Exelixis INC. | $162.77 | 2019-2025 | Cabometyx |
| Alexion Pharmaceuticals, INC. | $136.11 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $135.81 | 2019-2023 | Imbruvica |
| Epizyme, INC. | $134.84 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $131.44 | 2021-2025 | Vpriv |
| Coherus Oncology, INC. | $117.78 | 2021-2025 | Loqtorzi |
| Adc Therapeutics America, INC. | $117.44 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $102.61 | 2023-2025 | Orgovyx |
| Tempus Ai, INC | $100.25 | 2024-2025 | Xt Cdx |
| Emd Serono, INC. | $96.68 | 2019-2024 | Bavencio |
| Beone Medicines USA, INC. | $93.01 | 2025 | Brukinsa, Tevimbra |
| Morphosys, US INC. | $89.33 | 2021-2023 | Monjuvi |
| Puma Biotechnology, INC. | $87.53 | 2020-2025 | |
| Amag Pharmaceuticals, INC. | $86.66 | 2019-2021 | |
| Beigene USA, INC. | $85.76 | 2020-2022 | |
| Azurity Pharmaceuticals, INC. | $83.91 | 2024-2025 | Vivimusta, Danziten |
| Stemline Therapeutics INC. | $72.51 | 2023-2025 | Orserdu |
| Glaxosmithkline, LLC. | $71.77 | 2021-2025 | Ojjaara |
| Kite Pharma, INC. | $69.53 | 2021-2023 | Yescarta |
| Bayer Healthcare Pharmaceuticals INC. | $68.41 | 2019 | |
| Myovant Sciences INC. | $60.78 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $52.03 | 2023-2025 | Pylarify |
| Dova Pharmaceuticals | $50.51 | 2019-2021 | |
| Agios Pharmaceuticals, INC. | $45.27 | 2024-2025 | Pyrukynd |
| Karyopharm Therapeutics INC. | $35.71 | 2024 | Xpovio |
| Heron Therapeutics, INC. | $33.07 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $31.60 | 2022 | |
| Amneal Pharmaceuticals LLC | $27.38 | 2023-2024 | Avastin |
| Octapharma USA, INC. | $23.98 | 2019 | |
| Kyowa Kirin, INC. | $21.60 | 2019 | |
| Immunomedics, INC. | $21.34 | 2020 | |
| Mirati Therapeutics, INC. | $21.00 | 2023 | Krazati |
| Geron Corporation | $19.30 | 2025 | Rytelo |
| Legend Biotech USA INC. | $18.30 | 2025 | Carvykti |
| Adaptive Biotechnologies Corporation | $17.69 | 2025 | Clonoseq |
| Spectrum Pharmaceuticals INC. | $17.23 | 2024 | Rolvedon |
| Avyxa Pharma, LLC | $17.09 | 2025 | |
| Fortovia Therapeutics, INC. | $14.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zhao Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.